M
Mauro Carlino
Researcher at Vita-Salute San Raffaele University
Publications - 266
Citations - 14349
Mauro Carlino is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Percutaneous coronary intervention & Stent. The author has an hindex of 53, co-authored 258 publications receiving 13038 citations. Previous affiliations of Mauro Carlino include Università telematica San Raffaele.
Papers
More filters
Journal ArticleDOI
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
Ioannis Iakovou,Thomas Schmidt,Erminio Bonizzoni,Lei Ge,Giuseppe Sangiorgi,Goran Stankovic,Flavio Airoldi,Alaide Chieffo,Matteo Montorfano,Mauro Carlino,Iassen Michev,Nicola Corvaja,Carlo Briguori,Ulrich Gerckens,Eberhard Grube,Antonio Colombo +15 more
TL;DR: The cumulative incidence of stent thrombosis 9 months after successful drug-eluting stent implantation in consecutive "real-world" patients was substantially higher than the rate reported in clinical trials.
Journal ArticleDOI
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment
Flavio Airoldi,Antonio Colombo,Nuccia Morici,Azeem Latib,John Cosgrave,Lutz Buellesfeld,Erminio Bonizzoni,Mauro Carlino,Ulrich Gerckens,Cosmo Godino,Gloria Melzi,Iassen Michev,Matteo Montorfano,Giuseppe Sangiorgi,Asif Qasim,Alaide Chieffo,Carlo Briguori,Eberhard Grube +17 more
TL;DR: Discontinuation of thienopyridine therapy was the major determinant of ST within the first 6 months, but insufficient information is available to determine whether there is benefit in continuing a thienobyridine beyond 6 months.
Journal ArticleDOI
Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main
Alaide Chieffo,Goran Stankovic,Erminio Bonizzoni,Eleftheria Tsagalou,Ioannis Iakovou,Matteo Montorfano,Flavio Airoldi,Iassen Michev,Massimo Giuseppe Sangiorgi,Mauro Carlino,Giancarlo Vitrella,Antonio Colombo +11 more
TL;DR: This procedure appears safe with favorable and improved clinical results as compared with historical control subjects with a bare metal stent, and a randomized study comparing surgery appears justified at present.
Journal ArticleDOI
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL) A Randomized Comparison of 3 Preventive Strategies
Carlo Briguori,Flavio Airoldi,Davide D’Andrea,Erminio Bonizzoni,Nuccia Morici,Amelia Focaccio,Iassen Michev,Matteo Montorfano,Mauro Carlino,John Cosgrave,Bruno Ricciardelli,Antonio Colombo +11 more
TL;DR: The strategy of volume supplementation by sodium bicarbonate plus NAC seems to be superior to the combination of normal saline with NAC alone or with the addition of ascorbic acid in preventing CIN in patients at medium to high risk.
Journal ArticleDOI
Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis A Single-Center Experience
Alaide Chieffo,Nuccia Morici,Francesco Maisano,Erminio Bonizzoni,John Cosgrave,Matteo Montorfano,Flavio Airoldi,Mauro Carlino,Iassen Michev,Gloria Melzi,Giuseppe Sangiorgi,Ottavio Alfieri,Antonio Colombo +12 more
TL;DR: There was no difference in the degree of protection against death, stroke, myocardial infarction, and revascularization between PCI with DES and CABG for LMCA disease at 1 year.